1503 related articles for article (PubMed ID: 19242475)
21. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory.
Shankar GM; Li S; Mehta TH; Garcia-Munoz A; Shepardson NE; Smith I; Brett FM; Farrell MA; Rowan MJ; Lemere CA; Regan CM; Walsh DM; Sabatini BL; Selkoe DJ
Nat Med; 2008 Aug; 14(8):837-42. PubMed ID: 18568035
[TBL] [Abstract][Full Text] [Related]
22. Amyloid-β dimers in the absence of plaque pathology impair learning and synaptic plasticity.
Müller-Schiffmann A; Herring A; Abdel-Hafiz L; Chepkova AN; Schäble S; Wedel D; Horn AH; Sticht H; de Souza Silva MA; Gottmann K; Sergeeva OA; Huston JP; Keyvani K; Korth C
Brain; 2016 Feb; 139(Pt 2):509-25. PubMed ID: 26657517
[TBL] [Abstract][Full Text] [Related]
23. Monomeric amyloid-β reduced amyloid-β oligomer-induced synapse damage in neuronal cultures.
Bate C; Williams A
Neurobiol Dis; 2018 Mar; 111():48-58. PubMed ID: 29272738
[TBL] [Abstract][Full Text] [Related]
24. Accumulation of cellular prion protein within β-amyloid oligomer plaques in aged human brains.
Takahashi RH; Yokotsuka M; Tobiume M; Sato Y; Hasegawa H; Nagao T; Gouras GK
Brain Pathol; 2021 Sep; 31(5):e12941. PubMed ID: 33624334
[TBL] [Abstract][Full Text] [Related]
25. Hippocampal stem cells promotes synaptic resistance to the dysfunctional impact of amyloid beta oligomers via secreted exosomes.
Micci MA; Krishnan B; Bishop E; Zhang WR; Guptarak J; Grant A; Zolochevska O; Tumurbaatar B; Franklin W; Marino C; Widen SG; Luthra A; Kernie SG; Taglialatela G
Mol Neurodegener; 2019 Jun; 14(1):25. PubMed ID: 31200742
[TBL] [Abstract][Full Text] [Related]
26. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior.
Selkoe DJ
Behav Brain Res; 2008 Sep; 192(1):106-13. PubMed ID: 18359102
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
[TBL] [Abstract][Full Text] [Related]
28. Amyloid-β induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease.
Um JW; Strittmatter SM
Prion; 2013; 7(1):37-41. PubMed ID: 22987042
[TBL] [Abstract][Full Text] [Related]
29. Cellular prion protein as a therapeutic target in Alzheimer's disease.
Laurén J
J Alzheimers Dis; 2014; 38(2):227-44. PubMed ID: 23948943
[TBL] [Abstract][Full Text] [Related]
30. PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases.
Pietri M; Dakowski C; Hannaoui S; Alleaume-Butaux A; Hernandez-Rapp J; Ragagnin A; Mouillet-Richard S; Haik S; Bailly Y; Peyrin JM; Launay JM; Kellermann O; Schneider B
Nat Med; 2013 Sep; 19(9):1124-31. PubMed ID: 23955714
[TBL] [Abstract][Full Text] [Related]
31. Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss.
Salazar SV; Cox TO; Lee S; Brody AH; Chyung AS; Haas LT; Strittmatter SM
J Neurosci; 2019 Jan; 39(4):758-772. PubMed ID: 30518596
[TBL] [Abstract][Full Text] [Related]
32. The pathogenesis of soluble PrP fragments containing Aβ binding sites.
Li B
Virus Res; 2016 Jan; 211():194-8. PubMed ID: 26528810
[TBL] [Abstract][Full Text] [Related]
33. Memory impairment in transgenic Alzheimer mice requires cellular prion protein.
Gimbel DA; Nygaard HB; Coffey EE; Gunther EC; Laurén J; Gimbel ZA; Strittmatter SM
J Neurosci; 2010 May; 30(18):6367-74. PubMed ID: 20445063
[TBL] [Abstract][Full Text] [Related]
34. An N-terminal fragment of the prion protein binds to amyloid-β oligomers and inhibits their neurotoxicity in vivo.
Fluharty BR; Biasini E; Stravalaci M; Sclip A; Diomede L; Balducci C; La Vitola P; Messa M; Colombo L; Forloni G; Borsello T; Gobbi M; Harris DA
J Biol Chem; 2013 Mar; 288(11):7857-7866. PubMed ID: 23362282
[TBL] [Abstract][Full Text] [Related]
35. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
[TBL] [Abstract][Full Text] [Related]
36. Regulation of Amyloid β Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex.
Beraldo FH; Ostapchenko VG; Caetano FA; Guimaraes AL; Ferretti GD; Daude N; Bertram L; Nogueira KO; Silva JL; Westaway D; Cashman NR; Martins VR; Prado VF; Prado MA
J Biol Chem; 2016 Oct; 291(42):21945-21955. PubMed ID: 27563063
[TBL] [Abstract][Full Text] [Related]
37. Astrocytic glutamatergic transporters are involved in Aβ-induced synaptic dysfunction.
Huang S; Tong H; Lei M; Zhou M; Guo W; Li G; Tang X; Li Z; Mo M; Zhang X; Chen X; Cen L; Wei L; Xiao Y; Li K; Huang Q; Yang X; Liu W; Zhang L; Qu S; Li S; Xu P
Brain Res; 2018 Jan; 1678():129-137. PubMed ID: 29066369
[TBL] [Abstract][Full Text] [Related]
38. A d-enantiomeric peptide interferes with heteroassociation of amyloid-β oligomers and prion protein.
Rösener NS; Gremer L; Reinartz E; König A; Brener O; Heise H; Hoyer W; Neudecker P; Willbold D
J Biol Chem; 2018 Oct; 293(41):15748-15764. PubMed ID: 30131337
[TBL] [Abstract][Full Text] [Related]
39. Accumulation of intraneuronal β-amyloid 42 peptides is associated with early changes in microtubule-associated protein 2 in neurites and synapses.
Takahashi RH; Capetillo-Zarate E; Lin MT; Milner TA; Gouras GK
PLoS One; 2013; 8(1):e51965. PubMed ID: 23372648
[TBL] [Abstract][Full Text] [Related]
40. Alzheimer's disease brain-derived amyloid-β-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein.
Barry AE; Klyubin I; Mc Donald JM; Mably AJ; Farrell MA; Scott M; Walsh DM; Rowan MJ
J Neurosci; 2011 May; 31(20):7259-63. PubMed ID: 21593310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
